SCS Capital Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,867
Closed -$724K – 514
2026
Q2
$724K Hold
3,867
– – 0.01% 326
2026
Q1
$376K Hold
3,867
– – ﹤0.01% 383
2025
Q4
$308K Buy
+3,867
New +$254K ﹤0.01% 425

Other funds holding RVMD

SCS Capital Management's RVMD Position: Q3 2026 in Review

SCS Capital Management sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 3,867 shares — an estimated $724K sold.

SCS Capital Management first reported a position in RVMD in Q4 2025 and held it in 3 quarters. The position peaked at $724K in Q2 2026. 756 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • SCS Capital Management reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
  • SCS Capital Management sold 3,867 Revolution Medicines shares in Q3 2026, an estimated $724K.
  • SCS Capital Management first reported a position in Revolution Medicines in Q4 2025 and held it in 3 quarters.
  • SCS Capital Management's Revolution Medicines position peaked at $724K in Q2 2026.
  • 756 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on SCS Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.